Condition
Extrapulmonary Tuberculosis
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06875336RecruitingPrimary
A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
NCT04122404Not ApplicableCompletedPrimary
POC Strategies to Improve TB Care in Advanced HIV Disease
NCT01252992CompletedPrimary
Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis
NCT01613196Not ApplicableCompletedPrimary
Positron Emission Tomography in Extrapulmonary Tuberculosis
Showing all 4 trials